Biotech Startups

RNA NanoBiotics develops programmable RNA nanostructures that deliver multiple therapeutic payloads with defined stoichiometry and staggered intracellular release for difficult-to-treat cancers. Its lead program targets EpCAM-positive metastatic colorectal cancer by delivering the chemotherapeutic SN38, with planned expansion to multi-payload combinations across additional oncology indications.

1 investor

Develops precision RNA-based gene-regulating therapies aimed at treating serious diseases.

1 investor

Robo is an AI platform that automates research and evaluation of external biopharma assets, using AI agents to search across 100M+ primary data sources such as publications, trial registries, patents, and conference abstracts and score them against custom criteria. It serves business development and research teams in the biopharma industry.

1 investor

Roca Therapeutics develops first-in-class small molecule therapies for patients with neovascular retinal diseases. Founded in 2021 as a spin-off from Nice University and SATT Sud Est, the company is a biotech focused on ophthalmology drug development based in Nice, France.

1 investor

Roche is a healthcare company that develops diagnostics and pharmaceuticals aimed at preventing, treating, and curing diseases. It serves patients and health systems by combining biology, data, and AI in its research and development of medicines and diagnostic tools.

1 investor

Rockwell Medical is a publicly traded healthcare company (Nasdaq: RMTI) that develops, manufactures, and distributes a portfolio of hemodialysis products, including dialysis concentrates. It serves dialysis providers and patients with end-stage kidney disease worldwide.

1 investor

Roka Bioscience develops molecular testing assays and automated instrument systems for rapid pathogen detection in food manufacturing. The company serves food safety professionals and manufacturers seeking to reduce contamination risks and improve laboratory efficiency.

1 investor

Roka Furadada is a Barcelona-based deep biotech company that develops patented solar active ingredients for the cosmetics industry, including a photo-adaptive UVA absorber and upcycled lignin-based multifunctional actives for skin, sun, and hair care. It co-creates products with formulators, R&D leads, and marketing teams at cosmetics brands, guiding them from molecular design to market launch across global markets.

1 investor

Root Applied Sciences develops microbial detection and disease forecasting technology for agriculture, helping growers identify and prevent crop diseases. The company combines soil microbiology expertise with IoT and analytical instruments to deliver actionable pathogen detection and risk assessment for farmers.

1 investor

Rosalind builds a bioinformatics platform for analyzing genomics and multi-omics data, including bulk and single-cell RNA-seq, NanoString nCounter and GeoMx spatial transcriptomics, small RNA-seq, ChIP-seq, and ATAC-seq. It serves pharma, biotech, and academic researchers as well as service providers and contract research organizations.

1 investor

Rosebud Biosciences is an early-stage startup developing therapies for rare genetic diseases in children by modeling human development with patient-mutation-specific hiPSC-derived organoids and screening drugs in these models. It uses organoid models, robotics, and machine learning for drug discovery and seeks pharma partners working on heart, liver, neural, or kidney disease therapies.

1 investor

Rosetta Omics is a deeptech healthcare startup combining spatial multiomics profiling and AI to advance precision medicine in oncology. It develops technology for cancer diagnostics and clinical research, supported by a team of scientists, clinicians, and oncology experts.

1 investor

A website publishing research posts on pharmacological compounds, covering topics such as receptor antagonists, kinase inhibitors, and drug mechanisms in various disease models. The content focuses on biomedical and life-sciences research summaries.

1 investor

The Roskamp Institute conducts scientific research to develop therapies for neurological and neuropsychiatric conditions and to support healthy aging, running clinical studies and trials focused on brain health for its local community. It also offers a doctoral degree program in Neuroscience with laboratory-based research training.

1 investor

ROTOP develops, manufactures (cGMP), registers, and commercializes cold kits and radiopharmaceuticals used for diagnostic imaging and targeted therapy, with applications in oncology. It serves the nuclear medicine and precision diagnostics market, operating from Dresden, Germany.

1 investor

Rowan offers a web app and Python API for molecular design, simulation, and property prediction, including workflows for pKa, bond strength, redox potentials, protein-ligand binding affinity, and ADME properties. It serves drug discovery and materials science teams, letting them run computational chemistry workflows without maintaining their own compute infrastructure.

1 investor

The Royal Society of Chemistry is a professional membership organisation that connects the global chemistry community through partnerships, conferences, networks and publications. It sets standards for chemical scientists, promotes open access to scientific knowledge, and advocates for chemistry's role in addressing societal challenges including healthcare, environmental protection, and clean energy.

1 investor

Rubicon Research is a pharmaceutical formulations company focused on R&D of specialty products and drug-device combination products for regulated markets, including the US. It develops and manufactures formulations such as oral capsules, solutions, suspensions, tablets, ophthalmic drops, and intrathecal injections, and serves as a co-development and commercialization partner for early- and pre-clinical-stage companies.

1 investor

Rubryc discovers antibody-based medicines for obesity and cardiometabolic disease, using an AI-assisted platform to design antibodies for hard-to-drug targets. The company focuses on therapeutic development for patients with limited treatment options.

1 investor

Ruminant Biotech develops a rumen bolus that releases bromoform to reduce methane emissions from cattle by approximately 70%, supporting low-carbon livestock farming. The product targets dairy and beef producers seeking to lower greenhouse gas emissions while maintaining pasture-based grazing systems.

1 investor

RVL Pharmaceuticals develops prescription and skincare products for ocular and aesthetic care, including its flagship prescription eye drop Upneeq (oxymetazoline hydrochloride ophthalmic solution) and the Upneeq Reveal Under Eye Complex skincare product. It serves consumers and healthcare providers with tech-enabled access and integrated fulfillment.

1 investor

RxMP Therapeutics develops systemically-delivered hemostatic agents based on red cell-derived microparticles, intended to stop or prevent excessive bleeding from trauma, surgery, and bleeding disorders. The technology aims to improve healthcare outcomes and reduce the need for transfused blood products.

1 investor

S2Media is a certified woman-owned manufacturer of laboratory microbiological culture media, including custom and specialty media for research, clinical, and educational labs across North America. Its FDA-registered facility produces cGMP-compliant products aligned with standards such as USP, EPA, AOAC, and CLSI.

1 investor

SAB BIO is a clinical-stage biopharmaceutical company developing multi-specific human immunoglobulin G (hIgG) therapies to treat and prevent immune and autoimmune disorders, using genetically engineered transchromosomic cattle to produce therapeutic candidates. The company has advanced its lead candidate SAB-142 for Type 1 Diabetes into Phase 2b clinical trials.

1 investor